7003 A double blind, randomised, dose finding, phase II, multicentre study of radium-223 for the treatment of patients with metastatic castration-refractory prostate cancer (CRPC): EudraCT number: 2005–003680–22

✍ Scribed by Parker, C.; Hoskin, P.; Pascoe, S.; Chodack, A.; O'Sullivan, J.M.; Germá, J.R.; Lokna, A.

• Book ID: 121914678
• Publisher: Elsevier Science
• Year: 2009
• Tongue: English
• Weight: 49 KB
• Volume: 7
• Category: Article
• ISSN: 1359-6349
• DOI: 10.1016/S1359-6349(09)71381-3